Clinical trials
Terminated Phase 1 Obesity trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2009 | 2 |
| 2010 | 2 |
| 2012 | 3 |
| 2013 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 4 |
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 26 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Massachusetts General Hospital | 3 |
| Novo Nordisk A/S | 3 |
| Pfizer | 3 |
| Allysta Pharmaceutical | 1 |
| Amgen | 1 |
| Amy Arnold | 1 |
| AstraZeneca | 1 |
| Colorado State University | 1 |
| Columbia University | 1 |
| Eli Lilly and Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 26 |
| Overweight | 7 |
| Diabetes Mellitus, Type 2 | 4 |
| Aneurysm | 2 |
| Insulin Resistance | 2 |
| Nutrition Disorders | 2 |
| Diabetes Mellitus | 1 |
| Glucose Intolerance | 1 |
| Hyperinsulinism | 1 |
| Hyperlipidemias | 1 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.